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ABSTRACT
Chronic pain in the aged is a widespread phenomenon, and morphine is the most commonly used narcotic
analgesic for treatment. Despite that fact, there are relatively few published studies examining the impact
of advanced age on morphine analgesia. We hypothesized that aged rats would be less sensitive to
morphine than adults, and that aged animals would have reduced mu-opioid receptor (MOR) binding and
expression in the ventrolateral periaqueductal gray, a brain region responsible for morphine analgesia.
Using a model of persistent inflammatory pain, we found that morphine was significantly less effective in
aged males compared to adult males, and that aged males and females experience a reduction in MOR
binding and expression compared to adults. These results suggest that there are clear age differences in
morphine efficacy, and that reductions in MOR binding and expression in the periaqueductal gray could
underlie those differences.
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1 Introduction
As many as 70 percent of individuals over the age of 60 experience persistent or chronic pain.
While a significant portion of these individuals are treated with morphine, fewer than 1 percent of
published pain studies include the aged as a study population (Zwakhalen, Hamers et al. 2006). To date,
basic research on morphine analgesia has been carried out primarily on adult rats in good health, and none
to our knowledge look at age-related changes in opioid receptors. Given that there are over 600 million
people in the world over the age of 60 and that the 80+ age group is the fastest growing population
segment in the developed world (WHO 2008), it is crucial that we gain an understanding of the effects of
aging on the ability of morphine to modulate pain.
This project examined whether there were age related differences in morphine analgesia between
adult and aged rats in response to morphine administration following inflammatory injury, and age related
changes in the function of the µ opioid receptor (MOR) itself. Currently there are few published studies
examining age related differences in morphine analgesia. Of the studies that exist, many examine only
aged males (Goicoechea, Ormazabal et al. 1997; Ko, King et al. 1997; Jourdan, Pickering et al. 2002;
Crosby, Knapp et al. 2006), and to our knowledge all published pain studies in adult and aged rats
measure the effects of analgesics in uninjured animals. Clinically, analgesics are given to alleviate
moderate to severe acute and chronic pain, and aged individuals are highly unlikely to self administer or
be prescribed narcotics in non-pain states (Robinson 2008). To this end, subjects were tested using a
model of persistent inflammatory pain.
In addition to examining analgesic response between aged and adult rats we looked at changes in
brain regions responsible for morphine analgesia in the central nervous system. Morphine has been
demonstrated to act centrally in the midbrain ventrolateral periaqueductal gray (vlPAG) (Yaksh, Yeung et
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al. 1976), specifically on neurons containing MOR. This brain region is part of the descending pain
modulation circuit, with MOR-containing cells in this region projecting to the rostroventromedial medulla
(RVM) in the brainstem. Neurons project from this region to the dorsal horn of the spinal cord to
modulate the sensation of painful stimuli (Basbaum, Clanton et al. 1978).
Previous work from our laboratory has shown sex differences in morphine analgesia in rats, as
well as differences in MOR distribution and development of morphine tolerance (Loyd and Murphy 2006;
Wang, Traub et al. 2006; Loyd, Morgan et al. 2007; Loyd, Wang et al. 2008; Loyd, Morgan et al.
2008).Our results have shown that morphine is less effective in adult (60-90 day old) female rats than
male rats of the same age (Wang, Traub et al. 2006). Additional studies showed that sex differences in
morphine analgesia were the result of decreased MOR in the PAG of female rats.
The present experiments were designed to determine the impact of advanced age on morphine
analgesia. Additional experiments were conducted to determine whether observed changes in morphine
analgesia were due to changes in PAG MOR binding and/or expression.

2 Materials and Methods

2.1 Animal Subjects
Sprague Dawley rats were obtained from Charles River Laboratories. Adult males and females
were approximately 90 days of age. Aged subjects were retired breeders purchased at approximately 12
months of age and matured in-house to 18-24 months of age. This is commonly held in the literature as
“aged” (Jourdan, Boghossian et al. 2000). All animals were housed in same sex pairs. A 12:12 light
cycle was maintained throughout the experiment (lights on at 7:00 am EST), and food and water was
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available ad libitum. Aged rats were fed a reduced calorie diet for weight control (in pilot experiments no
differences were observed between aged rats fed standard chow vs. reduced calorie chow).

2.2 Inflammatory Injury
All groups were acclimated to testing equipment for two hours daily for a minimum of two weeks
before testing began. Twenty-four hours prior to CFA administration mechanical and thermal baseline
thresholds were measured (Paw thermal stimulator, UCSD; Dynamic plantar aesthesiometer, Ugo Basile).
For thermal paw withdrawal latency (PWL), a focused beam of light was directed towards the animal’s
hindpaw, and the latency to remove their hindpaw was recorded as paw withdrawal latency (PWL). To
assess mechanical thresholds, subjects were placed on a mesh platform and the dynamic plantar
aesthesiometer (Ugo Basile) was applied to the ventral aspect of the hindpaw. The device automatically
determined the force required to elicit a withdrawal. Following baseline measurement rats were given an
intraplantar injection of Complete Freund’s Adjuvant (CFA) (1 part CFA : 1part saline, Sigma), and
allowed to return to their home cage. Twenty-four hours later and prior to testing, inflammation was
verified by measuring the middle dorsoventral aspect of the injured hindpaw with a digital caliper and
compared to a measurement made pre-injury.

2.3 Thermal and Mechanical Hyperalgesia
Following paw measurement, rats were randomly assigned into either morphine or saline groups
and placed into the paw thermal stimulator. Following a 30 minute acclimation, post injury paw
withdrawal latencies were measured, mechanical hyperalgesia was measured, and morphine or saline was
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administered in an escalating dose (0, 1.8, 3.2, 5.6, 8, 10, and 18 mg/kg of morphine or 1ml/kg saline)
(Loyd, Wang et al. 2008). Doses were administered every 15 minutes, and paw withdrawal latencies
were measured immediately prior to next higher dose.

2.4 Sacrifice and Tissue Preparation
Animals used for immunohistochemistry were given an overdose of sodium pentobarbital (160
mg/kg, SleepAway, Fort Dodge (Wyeth), Madison, NJ) and perfused transcardially, first with 250-300ml
of sodium nitrite (a vasodilator), followed by 300 ml of a solution of 2.5% acrolein (poly sciences), 4%
paraformaldehyde (Sigma), and 0.175m potassium phosphate buffer. Brains were removed and placed in
a 30% sucrose (Sigma) phosphate buffer solution at 4 degrees C until sunk, placed on a freezing stage
microtome (Leics SM2000) and sectioned in a 1 to 6 series at 25 µm. Sections were stored in
cryoprotectant until processing.
Subjects used for autoradiography were rapidly decapitated, brains were quickly extracted and
snap frozen in isopentane chilled with dry ice. Following brain removal brains were sectioned in a 1 to 6
series with a cryostat (Leica CM3050S) at 20µm thickess and thaw mounted to slides. Slides containing
brain sections were stored in boxes containing desiccant (dririte) at -80 degrees C until processing.

2.5 Immunohistochemistry
Briefly, free floating tissue sections from aged and adult males and females (n=6 per group) were
rinsed of cryoprotectant with 0.175M KPBS (10x), incubated in 2% NaBH4 in KPBS for 20 minutes to
remove excess aldehydes, rinsed again, and incubated in primary antiserum (rabbit anti-MOR, 1:20,000
Chemicon) in the presence of 1%Triton x-100 at 4 degrees C for 48 hours. Next, tissue was rinsed of

5	
  
	
  
primary and incubated in biotinylated goat anti rabbit antibody for 1 hr in 0.4% triton x-100+KPBS
(biotinylated goat anti rabbit, Jackson Immunoresearch), rinsed again and incubated in in avidin biotin
complex (ABC elite kit, Vector Labs, Burlingame, CA) for 1 hour. Bound antibody was visualized using
nickel enhanced di-amino benzidine in a sodium acetate solution.

2.6 Autoradiography
Briefly, slides from animals in each group (n=6 per group) were air dried for at least 2 hours, then
fixed for 2 minutes in a 0.1% paraformaldehyde/PBS solution. Subsequently, the slides were rinsed in a
50mM TRIS solution with NaCl (15 min.), 50mM TRIS (15 min.) and then placed in tracer buffer for 60
minutes (1nM 3H DAMGO (Perkin Elmer), Bovine Serum Albumin, and TRIS (sigma)). Following
tracer incubation, tissue was rinsed (TRIS + MgCl 3x10 min. each, 30 sec dH2O) and slides were dried
overnight. Following tracer incubation, slides were apposed to tritium sensitive imaging plates (Fuji BAS
2025 TR) and exposed for 30 days. At the end of the exposure period imaging plates were read using the
Fuji BAS 5000 phosphoimager and resulting images were analyzed using Fuji Multi Gauge software.

2.7 Densitometry
To analyze tissue processed with immunohistochemistry grayscale images were obtained using a
Qimaging Retiga Exi ccd camera controlled by iVision software. The correct region and level of the PAG
was verified by comparison with Paxinos & Watson 1997. A square region of interest sample from the
vlPAG was taken from each section under 10x magnification and the optical density of the labeled tissue
was measured using iVision software. To control for non specific background labeling, an unlabeled
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region was sampled from each tissue section analyzed, and the density value derived from this was
subtracted from the optical density measurement value from the labeled area of interest (Loyd, Wang et
al. 2008).

2.8 Statistical Analysis
All group differences were measured using analysis of variance (ANOVA) using Prism (Graph
Pad). Post Hoc differences were calculated using Bonferroni’s multiple comparison test in Prism when
significant F scores were found. Dose response curves were plotted using the non-linear regression tool
in Prism (GraphPad).

3 Results

3.1 Baseline and Post Injury Hyperalgesia
No significant differences between aged and adult rats of either sex were noted for baseline
thermal and mechanical thresholds, indicating no effect of age on basal pain sensitivity. Indeed,
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uninjured animals did not differ in thermal nociception [F[3, 29] = 2.170, P = 0.113] (Figure 3.1.1).
Additionally, we noted no group differences in baseline mechanical nociception [F[3, 68] = 1.260, P =
0.2950] (Figure 3.1.2), change in thermal PWL following CFA [F[3, 46] = 0.5508, P = 0.6502] (Figure
3.1.3), or change in mechanical hyperalgesia following CFA [F[3, 39] = 0.3450, P = 0.7930] (Figure 3.1.4).
CFA injections caused the same degree of inflammation in adult and aged rats [F[3, 46] = 1.313, P =
0.2816] (Figure 3.1.5).

Figure 3.1.1 Baseline thermal hyperalgesia, reported as paw withdrawal latency (seconds)
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Figure 3.1.2 Baseline mechanical hyperalgesia, reported as grams of force required to elicit paw
withdrawal

Figure 3.1.3 Thermal hyperalgesia (extent of inflammatory hyperalgesia), calculated by
subtracting post inflammation PWLs from baseline values
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Figure 3.1.4 Mechanical hyperalgesia difference score (extent of mechanical hyperalgesia),
calculated by subtracting post inflammation scores from baseline value

Figure 3.1.5 Extent of inflammation, reported as percent change in paw diameter following CFA
administration
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3.2 Morphine Antihyperalgesia
Adult males and females showed a clear sex difference in response to morphine administration,
with females requiring a much higher dose (EC50=10.51 mg/kg) than males (EC50=3.82 mg/kg) to return
to baseline PWL. Male aged rats were much less sensitive to morphine than their adult counterparts, with
an EC50 of 9.153 mg/kg. Indeed, the EC50 of aged males was closer to that of adult and aged females
(EC50=10.51 mg/kg and 7.961 respectively). The decreased sensitivity of aged male rats to morphine
administration suggests that morphine is a less effective analgesic in aged male rats than it is in adult
males.

Figure 3.2.1 Thermal paw withdrawal latencies during cumulative morphine administration
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Figure 3.2.2 Response to cumulative morphine plotted as ED50

3.3 Immunohistochemistry
Next we tested whether the reduction in morphine efficacy was caused by a decrease in MOR in
the PAG. Immunohistochemical densitometry values indicated significant differences between aged and
adult subjects in both MOR expression and binding in the PAG. Using ANOVA there were significant
group differences in MOR distribution [F[3, 23] = 19.31, p<0.0001]. Using Bonferroni’s multiple
comparison test aged males (p <.001) and females (p <.001) showed significantly less MOR labeling than
their adult counterparts. Adult females exhibited reduced MOR labeling as well when compared to adult
males (p < .001). Neuronal Nuclei immunostaining revealed no significant differences between groups
[F[3, 21] = 1.858, p = 0.1677]
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Figure 3.3.1 MOR densitometry in the vlPAG: Aged females, males, and adult females all
exhibit significantly lower MOR labeling in vlPAG than adult males
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Figure 3.3.2 Representative sections from MOR immunohistochemistry in vlPAG
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Figure 3.3.3 Neuronal nuclei densitometry: there are no significant differences in neuronal
density in vlPAG between adult and aged animals of either sex

3.4 µ-opioid Receptor Autoradiography
In addition to examining differences in MOR expression, we also wanted to know whether there
were differences in MOR binding in the PAG. DAMGO autoradiography revealed significant differences
in MOR binding in the vlPAG [F[3, 21] = 11.69, p = 0.0001]. Post hoc, Bonferroni’s multiple comparisons
test revealed a significant age difference in males (p < 0.01), and a significant difference between adult
males and aged females (p < 0.05). This suggests a selective reduction in MOR binding in the vlPAG in
aged animals as compared to adult males (Figure 3.3.4)

15	
  
	
  

Figure 3.3.4 DAMGO binding in vlPAG: Aged males and females have significantly lower
binding compared to adult males
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Figure 3.3.5 Representative DAMGO autoradiograms in vlPAG: aged males and females show
reduced binding compared to adults
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4 Discussion

4.1 Overview
The purpose of these experiments was to examine age related differences in morphine analgesia
using a model of persistent inflammatory pain. Previous lab members have reported significant sex
differences in morphine analgesia using this model (Wang, Traub et al. 2006), and identified the vlPAG
as a critical region underlying the observed sex differences (Loyd and Murphy 2006; Loyd, Wang et al.
2008). The current experiments were designed to test the hypothesis that aged rats will be less sensitive
to morphine than their adult counterparts, and that there will be observable age differences in MOR
expression and binding in the vlPAG. The results of these experiments suggest that (A) Aged animals do
not have a different threshold for pain than their adult counterparts (figs. 3.1.1, 3.1.2); (B) Aged animals
did not differ in the hyperalgesia produced by inflammatory injury (figs. 3.1.3, 3.1.4); (C) Morphine was
less effective in aged males compared to adult males (fig. 3.2.1); (D) Aged males and females have
significantly lower MOR expression and binding in the vlPAG, a brain area shown to underly sex
differences in morphine analgesia (figs. 3.3.3, 3.3.4) (Loyd, Wang et al. 2008).
The results of these experiments indicate that there are clear age differences in morphine
analgesia, as well as differences in MOR expression and binding in brain regions shown to underlie
morphine analgesia. Further study is required to determine whether the observed changes in the brain are
the cause of the observed behavioral differences, but the experiments presented here provide a foundation
for future studies in the area.
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4.2 Thermal and Mechanical Hyperalgesia
Thermal and mechanical pain testing revealed no differences between aged and adult animals at
baseline and following inflammatory injury with CFA. This suggests that aged animals’ endogenous pain
modulation mechanisms are unaltered by age. This also indicates that the changes that we observed
behaviorally were due to actual differences in pain processing, rather than mechanical differences (i.e.
different skin thickness, fat pad thickness, etc.)

4.3 Morphine Antihyperalgesia
While others have reported sex and age differences in morphine analgesia in rats (Jourdan,
Boghossian et al. 2000; Jourdan, Pickering et al. 2002), none of the published studies were conducted
using a model of persistent inflammatory injury. CFA inflamed rats make a good model for analyzing
morphine efficacy because it more closely resembles the real-world clinical conditions under which
morphine is administered (Robinson 2008). The results that we obtained working within this model
support the hypothesis that there are age differences in morphine antihyperalgesia. While there were no
significant changes in morphine antihyperalgesia in aged females as compared to adults, aged males were
much less sensitive to morphine than their adult counterparts. Indeed, at 24 months of age, male rats
responded to a cumulative dose of morphine in a similar fashion to adult and aged females (Figure 3.2.1).
Indeed, compared to adult males, aged males experienced a two-fold rightward shift in ED50, or the dose
morphine required to return injured animals’ PWL to pre injury levels (Figure 3.2.2).
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4.4 Changes in MOR in vlPAG
Age differences in morphine analgesia are not dependent on pharmacokinetic differences (Wang,
Mitchell et al. 2005), so we sought to identify age and sex differences in MOR-containing neurons in
brain regions previously shown to mediate sex differences in morphine analgesia in adults, specifically
the caudal portion of the vlPAG (Basbaum, Clanton et al. 1978; Loyd and Murphy 2006; Loyd, Morgan
et al. 2007; Loyd, Wang et al. 2008). We sought to test the hypothesis that age subjects will exhibit
reduced MOR labeling in the vlPAG first with immunohistochemistry, where we showed that there was a
reduction in MOR protein levels, and second with Autoradiography, where we showed a corresponding
reduction in binding.
The results of the immunohistochemistry indicated reduced levels of MOR protein in aged
subjects as compared to adults. This result, however, should not be taken to mean that there is any change
in receptor binding, as immunohistochemistry uses an IgG antibody directed towards a unique amino acid
sequence in a receptor. As such, bound antibody indicates the location and density of the receptor, but
not its function. To test the hypothesis that aged rats will have reduced receptor function compared to
adults we used tritium labeled DAMGO autoradiography. Autoradiography is a better functional assay of
MOR activity because the labeled molecule is a MOR agonist, and binding of an agonist is a direct
biochemical measure of receptor function.
Previous lab members have demonstrated that vlPAG MOR containing neurons are essential for
systemic morphine analgesia (Loyd, Wang et al. 2008). In aged subjects, the reduction in MOR binding
that we observed in the vlPAG suggests that this could be the neural substrate for the behavioral changes
that we observed, particularly in males. In females there was a lack of behavioral differences between
aged and adult subjects, but aged males responded much differently than adult males. Loyd, Wang, et. al.
2008 demonstrate that site specific ablation of vlPAG MOR containing neurons is sufficient to reduce
morphine antihyperalgesia in males, but female adults receiving a MOR specific lesion to the vlPAG do
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not show a noticeable behavioral change. This suggests that other brain regions could be more extensively
involved in female morphine antihyperalgesia, and that mechanism is less affected by old age.
To control for the possibility that the changes that we observed could be due to a global loss in
neurons rather than a selective loss of MOR from aged and adult animals were stained for neuronal nuclei
(NeuN). We found no differences in the neuronal staining of aged animals as compared to adults, and no
sex differences. This suggests that the histological changes that we observed are consistent with an age
related decline in MOR function and expression levels rather than a generalized loss of neurons.

4.5 Concluding Remarks
The relative lack of studies examining age-related changes in morphine analgesia and associated
changes in descending pain circuits is alarming, and leaves little scientific background to inform
clinicians in the treatment of the aged. The rapidly aging global population deserves to be treated with
the same level of care with which adults and children are treated, and a better understanding of the aging
process and pain in the aged in basic models will help guide clinicians in their research.
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